R. Féty

发表

Population Pharmacokinetics and Pharmacodynamics of Doxorubicin and Cyclophosphamide in Breast Cancer Patients

D. Richel, J. Schellens, J. Beijnen, 2007, Clinical pharmacokinetics.

Central and peripheral changes in catecholamine-synthesizing enzyme activities after systemic administration of the neurotoxin DSP-4.

B. Renaud, L. Lambás-señas, R. Féty, 1986, European journal of pharmacology.

Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusion.

G. Milano, J. Lagrange, A. Thyss, 1993, Journal of the National Cancer Institute.

Hepatic arterial infusion of the nitrosourea derivate fotemustine for the treatment of liver metastases from colorectal carcinoma.

C. Bokemeyer, H. Schmoll, J. Hartmann, 1997, Oncology reports.

Docetaxel combined with vinorelbine: phase I results and new study designs.

P. Fumoleau, G. Perrocheau, N. Azli, 1997, Oncology.

Comparative responses of the central adrenaline- and noradrenaline-containing neurons after reserpine injections.

B. Renaud, G. Chamba, L. Lambás-señas, 1986, Biochemical pharmacology.

Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.

A Iliadis, G Milano, G. Milano, 1996, European journal of cancer.

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

J. Robert, E. Gamelin, M. Boisdron-Celle, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group

H. Hollema, A. Boddy, D. Richel, 2007, Clinical Cancer Research.

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.

Caen, T. Conroy, M. Barberi-Heyob, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT)

P. Fumoleau, A. Riva, C. Maugard, 1997 .

Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.

T. Conroy, M. Barberi-Heyob, J. Merlin, 1994, Anticancer research.

Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases.

C. Bokemeyer, H. Schmoll, J. Hartmann, 1998, European journal of cancer.

938 Docetaxel (D) in combination with vinorelbine (V) as first line CT in PTS with MBC: Phase I dose finding study

P. Fumoleau, A. Riva, G. Perrocheau, 1995 .

Hepatic intra-arterial infusion of fotemustine: pharmacokinetics

J. Vignoud, C. Lucas, V. Cour, 2004, Cancer Chemotherapy and Pharmacology.

Time course study of changes in the activity of the catecholamine synthesizing enzymes in the rat medulla oblongata after intraventricular injection of 6-hydroxydopamine

B. Renaud, R. Féty, 1983, Brain Research.

Changes in tyrosine hydroxylase and dopamine-beta-hydroxylase activities but not in phenylethanolamine-N-methyltransferase activity within central adrenaline neurons after 6-hydroxydopamine administration.

B. Renaud, G. Chamba, L. Lambás-señas, 1984, Biochemical pharmacology.